Nanjing, China

Xingran Chen

This inventor holds 1 USPTO granted patent. Top assignee: Nanjing Heron Pharmaceutical Science and Technology Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xingran Chen. Retrieved from https://idiyas.com/inventor/xingran-chen-bferc51w

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Xingran Chen in Pharmaceutical Science

Introduction

Xingran Chen is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceutical science, particularly in the development of new drug formulations. His work focuses on improving the efficacy and safety of existing medications.

Latest Patents

Xingran Chen holds a patent for a ketorolaco derivative, which is a pharmaceutical composition and preparation method. This innovative derivative demonstrates a better half-life and stability, along with improved pharmacokinetic properties. The ketorolaco derivative enhances efficacy while reducing toxicity, addressing common issues associated with traditional ketorolaco preparations, such as frequent administration and gastrointestinal side effects.

Career Highlights

Xingran Chen is affiliated with Nanjing Heron Pharmaceutical Science and Technology Co., Ltd. His work at this company has allowed him to focus on developing advanced pharmaceutical solutions that meet the needs of patients and healthcare providers.

Collaborations

Xingran Chen collaborates with talented professionals in his field, including Hai Ye and Tao Min. These partnerships contribute to the innovative research and development efforts at Nanjing Heron Pharmaceutical Science and Technology Co., Ltd.

Conclusion

Xingran Chen's contributions to pharmaceutical science, particularly through his patented ketorolaco derivative, highlight his commitment to improving drug formulations. His work continues to pave the way for advancements in medication safety and efficacy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…